Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
CB Financial Services
CBFV
$186M
| $1.19M | ﹤0.01% |
52,399
-400
| -0.8% | -$8.88K |
|
2227
Emergent Biosolutions
EBS
$377M
| $1.18M | ﹤0.01% |
173,747
-717,553
| -81% | -$3.09M |
|
2228
Vanguard Morningstar Small-Cap ETF
VB
$80.4B
| $1.18M | ﹤0.01% |
+5,400
| New | +$1.19M |
|
2229
Byline Bancorp
BY
$1.8B
| $1.17M | ﹤0.01% |
49,471
-19,800
| -29% | -$441K |
|
2230
Valley National Bancorp
VLY
$7.99B
| $1.17M | ﹤0.01% |
+168,256
| New | +$1.23M |
|
2231
SoundThinking
SSTI
$101M
| $1.17M | ﹤0.01% |
96,332
-1,573
| -2% | -$22.4K |
|
2232
America's Car Mart
CRMT
$27.9M
| $1.17M | ﹤0.01% |
19,472
-25,100
| -56% | -$1.52M |
|
2233
ARK 21Shares Bitcoin ETF
ARKB
$2.43B
| $1.17M | ﹤0.01% |
58,500
-39,000
| -40% | -$852K |
|
2234
Vanguard ESG US Stock ETF
ESGV
$13.3B
| $1.17M | ﹤0.01% |
12,100
+1,400
| +13% | +$130K |
|
2235
Vornado Realty Trust
VNO
$7.49B
| $1.17M | ﹤0.01% |
+44,399
| New | +$1.14M |
|
2236
eHealth
EHTH
$44.4M
| $1.17M | ﹤0.01% |
257,600
+131,772
| +105% | +$663K |
|
2237
Colony Bankcorp
CBAN
$465M
| $1.16M | ﹤0.01% |
95,078
+3,300
| +4% | +$37.6K |
|
2238
Landstar System
LSTR
$5.98B
| $1.16M | ﹤0.01% |
6,300
-32,640
| -84% | -$5.89M |
|
2239
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
| $1.16M | ﹤0.01% |
9,800
-24,100
| -71% | -$2.83M |
|
2240
iShares MSCI USA Quality Factor ETF
QUAL
$46.9B
| $1.16M | ﹤0.01% |
+6,800
| New | +$1.12M |
|
2241
Vanguard Consumer Staples ETF
VDC
$7.94B
| $1.16M | ﹤0.01% |
5,700
-3,100
| -35% | -$630K |
|
|
KC
2242
Kingsoft Cloud Holdings
KC
$3.64B
| $1.16M | ﹤0.01% |
460,400
+17,700
| +4% | +$52.3K |
|
2243
Kura Sushi USA
KRUS
$574M
| $1.15M | ﹤0.01% |
+18,300
| New | +$1.85M |
|
|
CWBC
2244
Community West Bancshares
CWBC
$692M
| $1.15M | ﹤0.01% |
62,345
+1,089
| +2% | +$19.1K |
|
2245
Aurinia Pharmaceuticals
AUPH
$1.87B
| $1.15M | ﹤0.01% |
201,500
-43,100
| -18% | -$227K |
|
|
GAN
2246
DELISTED
GAN Ltd
GAN
| $1.15M | ﹤0.01% |
777,817
+22,700
| +3% | +$30.2K |
|
2247
Great Elm Group
GEG
$70.6M
| $1.15M | ﹤0.01% |
637,276
-9,995
| -2% | -$18.3K |
|
2248
Crexendo
CXDO
$233M
| $1.15M | ﹤0.01% |
364,565
+254,065
| +230% | +$989K |
|
2249
Hanover Insurance
THG
$8.11B
| $1.14M | ﹤0.01% |
9,100
-28,000
| -75% | -$3.64M |
|
|
CDTX
2250
DELISTED
Cidara Therapeutics
CDTX
| $1.14M | ﹤0.01% |
95,517
-32,232
| -25% | -$441K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.